Elena Masselli: Can Statins Enhance Peginterferon Therapy in MPNs?
Elena Masselli, Full Professor of Human Anatomy at the University of Parma and Consultant Hematologist at the University Hospital of Parma, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Thrilled to share our commentary recently published in Blood Advances on the paper by Professor Hans Hasselbalch’s group exploring the clinically relevant synergy between peginterferon and statins in patients with myeloproliferative neoplasms.
Our article discusses the signalling pathways that may contribute to the synergistic effects of these treatments.
We are truly honoured to have received such positive feedback from the authors!
Take a look and let us know your thoughts!”
Title: Are statins interferon’s best friend? Mechanistic insights
Authors: Giacomo Maria Cerreto, Cecilia Carubbi, Marco Vitale, Elena Masselli
Stay updated with Hemostasis Today.
-
Jul 27, 2026, 13:45The Essentials of FFP Dosing and Monitoring – ICHCC
-
Jul 27, 2026, 13:27Antonio Lauletta: Distinguishing Sporadic and ICI-Related MG-Myositis Overlap
-
Jul 27, 2026, 13:15Satyam Arora: Welcoming the New ISBT Board and Looking Ahead
-
Jul 27, 2026, 13:03Jeff Parke: Why We Are Losing Viable Kidneys in Transit
-
Jul 27, 2026, 12:58George Hajishengallis: A New Era in Periodontal Disease Treatment
-
Jul 27, 2026, 12:32Sonia Elena Popovici: Redefining Hemorrhagic Shock Through Cellular and Molecular Insights
-
Jul 27, 2026, 12:24Abdul Mannan: Why Quantitative FXIII Testing Matters
-
Jul 27, 2026, 12:13Ney Carter Borges: Biomechanics of Plaque Erosion in ACS
-
Jul 27, 2026, 12:05Irma Bagdoniene: The Silent Progression of Coronary Artery Disease